Neuroendocrine liver metastasis: The chance to be cured after liver surgery

F Bagante, G Spolverato, K Merath, LM Postlewait, GA Poultsides, MG Mullen, TW Bauer, RC Fields, J Lamelas, HP Marques, L Aldrighetti, T Tran, SK Maithel, TM Pawlik

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

BACKGROUND AND OBJECTIVE: Neuroendocrine liver metastasis tumors (NELM) are a heterogeneous group of neoplasms with varied histologic features and a wide range of clinical behaviors. We aimed to identify the fraction of patients cured after liver surgery for NELM. METHODS: Cure fraction models were used to analyze 376 patients who underwent hepatectomy with curative intent for NELM. RESULTS: The median and 5-year disease-free survival (DFS) were 4.5 years and 46%, respectively. The probability of being cured from NELM by liver surgery was 44%; the time to cure was 5.1 years. In a multivariable cure model, type of neuroendocrine tumor (NET), grade of tumor differentiation, and rate of liver involvement resulted as independent predictors of cure. The cure fraction for patients with well differentiated NELM from gastrointestinal NET or a functional pancreatic NET, and with50%, moderately/poorly differentiation), the cure fraction was 8%. CONCLUSIONS: Statistical cure after surgery for NELM is possible, and allow for a more accurate prediction of long-term outcome among patients with NELM undergoing liver resection. © 2017 Wiley Periodicals, Inc.
Original languageEnglish
Pages (from-to)687-695
Number of pages9
JournalJournal of Surgical Oncology
Volume115
Issue number6
DOIs
Publication statusPublished - 2017

Fingerprint

Neoplasm Metastasis
Liver
Neoplasms
Neuroendocrine Tumors
Hepatectomy
Disease-Free Survival

Cite this

Bagante, F., Spolverato, G., Merath, K., Postlewait, LM., Poultsides, GA., Mullen, MG., ... Pawlik, TM. (2017). Neuroendocrine liver metastasis: The chance to be cured after liver surgery. Journal of Surgical Oncology, 115(6), 687-695. https://doi.org/10.1002/jso.24563

Neuroendocrine liver metastasis: The chance to be cured after liver surgery. / Bagante, F; Spolverato, G; Merath, K; Postlewait, LM; Poultsides, GA; Mullen, MG; Bauer, TW; Fields, RC; Lamelas, J; Marques, HP; Aldrighetti, L; Tran, T; Maithel, SK; Pawlik, TM.

In: Journal of Surgical Oncology, Vol. 115, No. 6, 2017, p. 687-695.

Research output: Contribution to journalArticle

Bagante, F, Spolverato, G, Merath, K, Postlewait, LM, Poultsides, GA, Mullen, MG, Bauer, TW, Fields, RC, Lamelas, J, Marques, HP, Aldrighetti, L, Tran, T, Maithel, SK & Pawlik, TM 2017, 'Neuroendocrine liver metastasis: The chance to be cured after liver surgery', Journal of Surgical Oncology, vol. 115, no. 6, pp. 687-695. https://doi.org/10.1002/jso.24563
Bagante F, Spolverato G, Merath K, Postlewait LM, Poultsides GA, Mullen MG et al. Neuroendocrine liver metastasis: The chance to be cured after liver surgery. Journal of Surgical Oncology. 2017;115(6):687-695. https://doi.org/10.1002/jso.24563
Bagante, F ; Spolverato, G ; Merath, K ; Postlewait, LM ; Poultsides, GA ; Mullen, MG ; Bauer, TW ; Fields, RC ; Lamelas, J ; Marques, HP ; Aldrighetti, L ; Tran, T ; Maithel, SK ; Pawlik, TM. / Neuroendocrine liver metastasis: The chance to be cured after liver surgery. In: Journal of Surgical Oncology. 2017 ; Vol. 115, No. 6. pp. 687-695.
@article{f7d4bf666a4e42a395bc28e942732951,
title = "Neuroendocrine liver metastasis: The chance to be cured after liver surgery",
abstract = "BACKGROUND AND OBJECTIVE: Neuroendocrine liver metastasis tumors (NELM) are a heterogeneous group of neoplasms with varied histologic features and a wide range of clinical behaviors. We aimed to identify the fraction of patients cured after liver surgery for NELM. METHODS: Cure fraction models were used to analyze 376 patients who underwent hepatectomy with curative intent for NELM. RESULTS: The median and 5-year disease-free survival (DFS) were 4.5 years and 46{\%}, respectively. The probability of being cured from NELM by liver surgery was 44{\%}; the time to cure was 5.1 years. In a multivariable cure model, type of neuroendocrine tumor (NET), grade of tumor differentiation, and rate of liver involvement resulted as independent predictors of cure. The cure fraction for patients with well differentiated NELM from gastrointestinal NET or a functional pancreatic NET, and with50{\%}, moderately/poorly differentiation), the cure fraction was 8{\%}. CONCLUSIONS: Statistical cure after surgery for NELM is possible, and allow for a more accurate prediction of long-term outcome among patients with NELM undergoing liver resection. {\circledC} 2017 Wiley Periodicals, Inc.",
author = "F Bagante and G Spolverato and K Merath and LM Postlewait and GA Poultsides and MG Mullen and TW Bauer and RC Fields and J Lamelas and HP Marques and L Aldrighetti and T Tran and SK Maithel and TM Pawlik",
year = "2017",
doi = "10.1002/jso.24563",
language = "English",
volume = "115",
pages = "687--695",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Neuroendocrine liver metastasis: The chance to be cured after liver surgery

AU - Bagante, F

AU - Spolverato, G

AU - Merath, K

AU - Postlewait, LM

AU - Poultsides, GA

AU - Mullen, MG

AU - Bauer, TW

AU - Fields, RC

AU - Lamelas, J

AU - Marques, HP

AU - Aldrighetti, L

AU - Tran, T

AU - Maithel, SK

AU - Pawlik, TM

PY - 2017

Y1 - 2017

N2 - BACKGROUND AND OBJECTIVE: Neuroendocrine liver metastasis tumors (NELM) are a heterogeneous group of neoplasms with varied histologic features and a wide range of clinical behaviors. We aimed to identify the fraction of patients cured after liver surgery for NELM. METHODS: Cure fraction models were used to analyze 376 patients who underwent hepatectomy with curative intent for NELM. RESULTS: The median and 5-year disease-free survival (DFS) were 4.5 years and 46%, respectively. The probability of being cured from NELM by liver surgery was 44%; the time to cure was 5.1 years. In a multivariable cure model, type of neuroendocrine tumor (NET), grade of tumor differentiation, and rate of liver involvement resulted as independent predictors of cure. The cure fraction for patients with well differentiated NELM from gastrointestinal NET or a functional pancreatic NET, and with50%, moderately/poorly differentiation), the cure fraction was 8%. CONCLUSIONS: Statistical cure after surgery for NELM is possible, and allow for a more accurate prediction of long-term outcome among patients with NELM undergoing liver resection. © 2017 Wiley Periodicals, Inc.

AB - BACKGROUND AND OBJECTIVE: Neuroendocrine liver metastasis tumors (NELM) are a heterogeneous group of neoplasms with varied histologic features and a wide range of clinical behaviors. We aimed to identify the fraction of patients cured after liver surgery for NELM. METHODS: Cure fraction models were used to analyze 376 patients who underwent hepatectomy with curative intent for NELM. RESULTS: The median and 5-year disease-free survival (DFS) were 4.5 years and 46%, respectively. The probability of being cured from NELM by liver surgery was 44%; the time to cure was 5.1 years. In a multivariable cure model, type of neuroendocrine tumor (NET), grade of tumor differentiation, and rate of liver involvement resulted as independent predictors of cure. The cure fraction for patients with well differentiated NELM from gastrointestinal NET or a functional pancreatic NET, and with50%, moderately/poorly differentiation), the cure fraction was 8%. CONCLUSIONS: Statistical cure after surgery for NELM is possible, and allow for a more accurate prediction of long-term outcome among patients with NELM undergoing liver resection. © 2017 Wiley Periodicals, Inc.

U2 - 10.1002/jso.24563

DO - 10.1002/jso.24563

M3 - Article

VL - 115

SP - 687

EP - 695

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 6

ER -